Efficacy and safety of the TRPV1 agonist RTX-GRT7039 in patients with pain associated with knee osteoarthritis: Results from a phase 3, randomised, placebo-controlled trial
Efficacy and safety of the TRPV1 agonist RTX-GRT7039 in patients with pain associated with knee osteoarthritis: Results from a phase 3, randomised, placebo-controlled trial. // Osteoarthritis and Cartilage. – URL: https://www.sciencedirect.com/science/article/pii/S1063458426010927?dgcid=rss_sd_all
Efficacy and safety of the TRPV1 agonist RTX-GRT7039 in patients with pain associated with knee osteoarthritis: Results from a phase 3, randomised, placebo-controlled trial. Osteoarthritis and Cartilage. https://www.sciencedirect.com/science/article/pii/S1063458426010927?dgcid=rss_sd_all
“Efficacy and safety of the TRPV1 agonist RTX-GRT7039 in patients with pain associated with knee osteoarthritis: Results from a phase 3, randomised, placebo-controlled trial.” Osteoarthritis and Cartilage.
@article{article61571,
title = {Efficacy and safety of the TRPV1 agonist RTX-GRT7039 in patients with pain associated with knee osteoarthritis: Results from a phase 3, randomised, placebo-controlled trial},
journal = {Osteoarthritis and Cartilage},
url = {https://www.sciencedirect.com/science/article/pii/S1063458426010927?dgcid=rss_sd_all}
}